US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 19.530
  • -1.030-5.01%
Close Dec 11 16:00 ET
  • 19.530
  • 0.0000.00%
Post 20:01 ET
344.02MMarket Cap72.33P/E (TTM)

Rigel Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1,695.22%21.68M
-94.91%302K
-23.05%-5.01M
92.21%-5.74M
71.52%-6.24M
89.78%-1.36M
145.93%5.93M
84.11%-4.07M
-1,354.81%-73.76M
-14.79%-21.91M
Net income from continuing operations
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
Operating gains losses
----
----
----
292.75%266K
-133.64%-110K
89.62%-22K
--51K
--347K
---138K
--327K
Depreciation and amortization
109.25%611K
107.09%613K
12.04%400K
24.05%1.24M
3.17%293K
21.67%292K
24.89%296K
50.63%357K
-14.11%998K
-29.70%284K
Other non cash items
----
----
----
----
----
----
----
----
-78.27%682K
--0
Change In working capital
173.93%6.1M
-116.41%-1.65M
-134.53%-2.1M
132.76%9.52M
68.25%-8.83M
-25.64%2.23M
636.95%10.06M
358.65%6.07M
-398.92%-29.05M
-21,467.44%-27.82M
-Change in receivables
38.72%-1.67M
-116.29%-1.39M
-72.27%3.04M
139.32%9.77M
71.75%-7M
-263.00%-2.73M
536.52%8.55M
4,621.55%10.95M
-5,059.68%-24.85M
-5,054.89%-24.8M
-Change in inventory
1,090.04%3.34M
-810.36%-2.2M
-18.52%-2.31M
149.31%1.17M
227.63%2.53M
132.04%281K
-48.07%309K
-1,640.18%-1.95M
51.24%-2.38M
-540.67%-1.98M
-Change in prepaid assets
-172.03%-1.4M
-83.46%496K
-759.18%-2.58M
335.89%2M
-58.47%-3.33M
8.75%1.94M
103.18%3M
119.57%392K
-112.77%-847K
-42.03%-2.1M
-Change in payables and accrued expense
-76.33%640K
3.64%-2.17M
184.54%2.85M
-302.48%-5.71M
-155.96%-2.79M
308.96%2.7M
27.59%-2.25M
-250.99%-3.37M
-48.82%2.82M
608.97%4.99M
-Change in other current assets
1,509.09%155K
442.86%152K
-83.54%149K
-86.12%1.13M
-77.57%203K
-100.51%-11K
-98.81%28K
-66.24%905K
0.81%8.11M
-56.53%905K
-Change in other current liabilities
92.04%-173K
27.35%-170K
-142.21%-168K
83.41%-2.17M
97.25%-162K
12.98%-2.17M
90.01%-234K
116.90%398K
-51.77%-13.08M
-163.25%-5.89M
-Change in other working capital
134.79%5.2M
449.85%3.63M
-143.19%-3.07M
182.87%3.34M
64.35%1.72M
8.91%2.21M
-41.02%660K
58.23%-1.26M
-53.33%1.18M
-58.34%1.05M
Cash from discontinued investing activities
Operating cash flow
1,695.22%21.68M
-94.91%302K
-23.05%-5.01M
92.21%-5.74M
71.52%-6.24M
89.78%-1.36M
145.93%5.93M
84.11%-4.07M
-1,354.81%-73.76M
-14.79%-21.91M
Investing cash flow
Cash flow from continuing investing activities
424.96%3.8M
267.98%10.93M
-59.72%313K
-105.90%-4.3M
-136.96%-6.87M
-111.19%-1.17M
-85.92%2.97M
-96.57%777K
190.93%72.78M
186.65%18.6M
Net PPE purchase and sale
18.18%26K
--0
--0
-41.53%259K
-60.29%110K
-75.56%22K
--0
156.70%127K
170.65%443K
--277K
Net intangibles purchase and sale
--0
---222K
99.08%-138K
---15M
--0
--0
--0
---15M
--0
--0
Net investment purchase and sale
417.62%3.79M
275.45%11.15M
-97.12%451K
-85.56%10.44M
-138.12%-6.98M
-111.50%-1.19M
-85.72%2.97M
-31.52%15.65M
191.09%72.33M
183.30%18.32M
Cash from discontinued investing activities
Investing cash flow
424.96%3.8M
267.98%10.93M
-59.72%313K
-105.90%-4.3M
-136.96%-6.87M
-111.19%-1.17M
-85.92%2.97M
-96.57%777K
190.93%72.78M
186.65%18.6M
Financing cash flow
Cash flow from continuing financing activities
-1,032.57%-9.84M
-101.61%-752K
-113.14%-2.51M
180.41%18.37M
123.19%486K
-115.77%-869K
93.41%-373K
117.38%19.12M
-89.55%6.55M
-293.18%-2.1M
Net issuance payments of debt
--0
--0
--0
2.09%19.95M
--0
--0
--0
100.00%19.95M
--19.54M
--0
Proceeds from stock option exercised by employees
1,655.56%158K
-54.43%252K
8,800.00%89K
-50.61%1.05M
-16.92%486K
--9K
-7.68%553K
-99.89%1K
-55.52%2.12M
-46.08%585K
Net other financing activities
-1,038.95%-10M
-8.42%-1M
-214.13%-2.6M
82.59%-2.63M
--0
78.53%-878K
85.13%-926K
60.91%-828K
-126.11%-15.12M
---2.68M
Cash from discontinued financing activities
Financing cash flow
-1,032.57%-9.84M
-101.61%-752K
-113.14%-2.51M
180.41%18.37M
123.19%486K
-115.77%-869K
93.41%-373K
117.38%19.12M
-89.55%6.55M
-293.18%-2.1M
Net cash flow
Beginning cash position
-26.14%36.05M
-36.52%25.57M
34.04%32.79M
29.48%24.46M
52.06%45.41M
79.45%48.81M
63.24%40.29M
29.48%24.46M
-37.81%18.89M
-1.77%29.87M
Current changes in cash
560.24%15.64M
22.89%10.48M
-145.57%-7.21M
49.52%8.33M
-133.55%-12.63M
-227.50%-3.4M
238.10%8.53M
173.38%15.83M
148.50%5.57M
53.04%-5.41M
End cash Position
13.82%51.69M
-26.14%36.05M
-36.52%25.57M
34.04%32.79M
34.04%32.79M
52.06%45.41M
79.45%48.81M
63.24%40.29M
29.48%24.46M
29.48%24.46M
Free cash flow
1,694.48%21.67M
-98.65%80K
72.99%-5.15M
72.05%-20.74M
71.61%-6.24M
89.93%-1.36M
146.06%5.93M
26.24%-19.07M
-1,513.22%-74.21M
-15.30%-21.98M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1,695.22%21.68M-94.91%302K-23.05%-5.01M92.21%-5.74M71.52%-6.24M89.78%-1.36M145.93%5.93M84.11%-4.07M-1,354.81%-73.76M-14.79%-21.91M
Net income from continuing operations 318.22%12.42M84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M
Operating gains losses ------------292.75%266K-133.64%-110K89.62%-22K--51K--347K---138K--327K
Depreciation and amortization 109.25%611K107.09%613K12.04%400K24.05%1.24M3.17%293K21.67%292K24.89%296K50.63%357K-14.11%998K-29.70%284K
Other non cash items ---------------------------------78.27%682K--0
Change In working capital 173.93%6.1M-116.41%-1.65M-134.53%-2.1M132.76%9.52M68.25%-8.83M-25.64%2.23M636.95%10.06M358.65%6.07M-398.92%-29.05M-21,467.44%-27.82M
-Change in receivables 38.72%-1.67M-116.29%-1.39M-72.27%3.04M139.32%9.77M71.75%-7M-263.00%-2.73M536.52%8.55M4,621.55%10.95M-5,059.68%-24.85M-5,054.89%-24.8M
-Change in inventory 1,090.04%3.34M-810.36%-2.2M-18.52%-2.31M149.31%1.17M227.63%2.53M132.04%281K-48.07%309K-1,640.18%-1.95M51.24%-2.38M-540.67%-1.98M
-Change in prepaid assets -172.03%-1.4M-83.46%496K-759.18%-2.58M335.89%2M-58.47%-3.33M8.75%1.94M103.18%3M119.57%392K-112.77%-847K-42.03%-2.1M
-Change in payables and accrued expense -76.33%640K3.64%-2.17M184.54%2.85M-302.48%-5.71M-155.96%-2.79M308.96%2.7M27.59%-2.25M-250.99%-3.37M-48.82%2.82M608.97%4.99M
-Change in other current assets 1,509.09%155K442.86%152K-83.54%149K-86.12%1.13M-77.57%203K-100.51%-11K-98.81%28K-66.24%905K0.81%8.11M-56.53%905K
-Change in other current liabilities 92.04%-173K27.35%-170K-142.21%-168K83.41%-2.17M97.25%-162K12.98%-2.17M90.01%-234K116.90%398K-51.77%-13.08M-163.25%-5.89M
-Change in other working capital 134.79%5.2M449.85%3.63M-143.19%-3.07M182.87%3.34M64.35%1.72M8.91%2.21M-41.02%660K58.23%-1.26M-53.33%1.18M-58.34%1.05M
Cash from discontinued investing activities
Operating cash flow 1,695.22%21.68M-94.91%302K-23.05%-5.01M92.21%-5.74M71.52%-6.24M89.78%-1.36M145.93%5.93M84.11%-4.07M-1,354.81%-73.76M-14.79%-21.91M
Investing cash flow
Cash flow from continuing investing activities 424.96%3.8M267.98%10.93M-59.72%313K-105.90%-4.3M-136.96%-6.87M-111.19%-1.17M-85.92%2.97M-96.57%777K190.93%72.78M186.65%18.6M
Net PPE purchase and sale 18.18%26K--0--0-41.53%259K-60.29%110K-75.56%22K--0156.70%127K170.65%443K--277K
Net intangibles purchase and sale --0---222K99.08%-138K---15M--0--0--0---15M--0--0
Net investment purchase and sale 417.62%3.79M275.45%11.15M-97.12%451K-85.56%10.44M-138.12%-6.98M-111.50%-1.19M-85.72%2.97M-31.52%15.65M191.09%72.33M183.30%18.32M
Cash from discontinued investing activities
Investing cash flow 424.96%3.8M267.98%10.93M-59.72%313K-105.90%-4.3M-136.96%-6.87M-111.19%-1.17M-85.92%2.97M-96.57%777K190.93%72.78M186.65%18.6M
Financing cash flow
Cash flow from continuing financing activities -1,032.57%-9.84M-101.61%-752K-113.14%-2.51M180.41%18.37M123.19%486K-115.77%-869K93.41%-373K117.38%19.12M-89.55%6.55M-293.18%-2.1M
Net issuance payments of debt --0--0--02.09%19.95M--0--0--0100.00%19.95M--19.54M--0
Proceeds from stock option exercised by employees 1,655.56%158K-54.43%252K8,800.00%89K-50.61%1.05M-16.92%486K--9K-7.68%553K-99.89%1K-55.52%2.12M-46.08%585K
Net other financing activities -1,038.95%-10M-8.42%-1M-214.13%-2.6M82.59%-2.63M--078.53%-878K85.13%-926K60.91%-828K-126.11%-15.12M---2.68M
Cash from discontinued financing activities
Financing cash flow -1,032.57%-9.84M-101.61%-752K-113.14%-2.51M180.41%18.37M123.19%486K-115.77%-869K93.41%-373K117.38%19.12M-89.55%6.55M-293.18%-2.1M
Net cash flow
Beginning cash position -26.14%36.05M-36.52%25.57M34.04%32.79M29.48%24.46M52.06%45.41M79.45%48.81M63.24%40.29M29.48%24.46M-37.81%18.89M-1.77%29.87M
Current changes in cash 560.24%15.64M22.89%10.48M-145.57%-7.21M49.52%8.33M-133.55%-12.63M-227.50%-3.4M238.10%8.53M173.38%15.83M148.50%5.57M53.04%-5.41M
End cash Position 13.82%51.69M-26.14%36.05M-36.52%25.57M34.04%32.79M34.04%32.79M52.06%45.41M79.45%48.81M63.24%40.29M29.48%24.46M29.48%24.46M
Free cash flow 1,694.48%21.67M-98.65%80K72.99%-5.15M72.05%-20.74M71.61%-6.24M89.93%-1.36M146.06%5.93M26.24%-19.07M-1,513.22%-74.21M-15.30%-21.98M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.